Page last updated: 2024-08-24

dexmedetomidine and Acute Confusional Senile Dementia

dexmedetomidine has been researched along with Acute Confusional Senile Dementia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Hu, G; Shao, W; Shi, Z; Xu, B1
Liu, L; Sun, Y; Tan, Q; Wang, Q; Wang, S1
Li, C; Sun, W; Zhao, J1
Jia, A; Ma, W; Wang, Y1

Other Studies

4 other study(ies) available for dexmedetomidine and Acute Confusional Senile Dementia

ArticleYear
MicroRNA-214-5p involves in the protection effect of Dexmedetomidine against neurological injury in Alzheimer's disease via targeting the suppressor of zest 12.
    Brain research bulletin, 2022, Volume: 178

    Topics: Alzheimer Disease; Animals; Dexmedetomidine; Disease Models, Animal; Hippocampus; Mice; MicroRNAs; Neuroprotective Agents; Polycomb Repressive Complex 2

2022
Dexmedetomidine Promoted HSPB8 Expression via Inhibiting the lncRNA SNHG14/UPF1 Axis to Inhibit Apoptosis of Nerve Cells in AD : The Role of Dexmedetomidine in AD.
    Neurotoxicity research, 2023, Volume: 41, Issue:5

    Topics: Alzheimer Disease; Apoptosis; Dexmedetomidine; Heat-Shock Proteins; Humans; Molecular Chaperones; Neuroblastoma; Neurons; RNA Helicases; RNA, Long Noncoding; Trans-Activators

2023
Dexmedetomidine Provides Protection Against Hippocampal Neuron Apoptosis and Cognitive Impairment in Mice with Alzheimer's Disease by Mediating the miR-129/YAP1/JAG1 Axis.
    Molecular neurobiology, 2020, Volume: 57, Issue:12

    Topics: Adaptor Proteins, Signal Transducing; Alzheimer Disease; Animals; Apoptosis; Base Sequence; Cognitive Dysfunction; Dexmedetomidine; Gene Expression Regulation; Hippocampus; Jagged-1 Protein; Male; Mice; MicroRNAs; Models, Biological; Neurons; Neuroprotection; Neuroprotective Agents; Protein Binding; Signal Transduction; YAP-Signaling Proteins

2020
Dexmedetomidine attenuates the toxicity of β‑amyloid on neurons and astrocytes by increasing BDNF production under the regulation of HDAC2 and HDAC5.
    Molecular medicine reports, 2019, Volume: 19, Issue:1

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Astrocytes; Brain-Derived Neurotrophic Factor; Cell Nucleus; Cells, Cultured; Cerebral Cortex; Dexmedetomidine; Hippocampus; Histone Deacetylase 2; Histone Deacetylase Inhibitors; Histone Deacetylases; Neurons; Neuroprotection; Neuroprotective Agents; Rats; Rats, Sprague-Dawley

2019